Backtable Cardiology

BackTable Brief: COSIRA II: Coronary Sinus Reducer: A Tool in Angina Care with Dr. Jai Khatri

Tue, 14 Apr 2026 07:00:00 -0000

Summary

This week, the coronary sinus isn’t the only thing getting reduced! Dr. Jai Khatri and Dr. Ziad Ali join this BackTable Brief to share strategies for reducing enrollment barriers for the COSIRA II coronary sinus reducer trial. They discuss refractory angina, emerging evidence for microvascular angina, and strategies to help patients achieve stable medical therapy and avoid resetting trial eligibility.

TIMESTAMPS

00:00 - Introduction

01:46 - Maintaining Patients Eligibility

04:20 - Treadmill Test Reproducibility

07:16 - Patient Stories And Outcomes

11:39 - CTO vs. COSIRA-II Trial Candidacy

16:57 - Microvascular Angina: Evidence and Outlook

CHECK OUT THE FULL EPISODE

COSIRA II: Managing Refractory Angina in Clinical Practice

https://www.backtable.com/shows/cardiology/podcasts/14/cosira-ii-refractory-angina-challenges-treatment-strategies

RESOURCES

COSIRA-II Trial
https://clinicaltrials.gov/study/NCT05102019

BackTable Brief: COSIRA II: Managing Refractory Angina in Clinical Practice with Dr. Jai Khatri

Tue, 07 Apr 2026 07:00:00 -0000

Coronary sinus reducers: the hourglass-shaped stents that might be able to take patients back to angina-free times. In this BackTable Cardiology Brief, Dr. Jai Khatri and Dr. Ziad Ali discuss patient selection, treatment algorithms, and recent, clinical-trial backed technology for treating diffuse, multi-vessel atherosclerotic disease. They emphasize staged PCI, careful counseling, and setting realistic expectations when angiographic success doesn’t translate to symptom relief.

Notably, the episode introduces the coronary sinus reducer, tracing the stent’s roots back to the Beck procedure of the 1950s. Drs. Jai and Khatri review the stent’s mechanism in the coronary sinus and review key coronary sinus reducer trials: COSIRA and COSIRA-II. The delve into COSIRA-II’s design, inclusion criteria, and best practices and recommendations for enrolling patients.

---

Timestamps

00:00 - Introduction

00:59 - Diffuse Disease Challenges

02:42 - Patient Communication: Setting Expectations

05:06 - Treatment Algorithms: PCI vs CABG

07:22 - When PCI Fails Symptoms

08:35 - Coronary Sinus Reducers

10:52 - COSIRA Evidence

12:01 - COSIRA II Design

13:13 - Why Sham Control Matters

14:30 - Reducer Procedure Walkthrough

16:54 - Risks And Safety

18:41 - Enrollment And Criteria

20:11 - Wrap Up And Credits

---

Check out the full episode

COSIRA II: Managing Refractory Angina in Clinical Practice

https://www.backtable.com/shows/cardiology/podcasts/14/cosira-ii-refractory-angina-challenges-treatment-strategies

---

Resources

COSIRA-II Trial

https://clinicaltrials.gov/study/NCT05102019

Ep. 31 Advancements in Carotid Stenting with Dr. Adnan Siddiqui

Tue, 31 Mar 2026 07:00:00 -0000

Clean lumen club! This week, BackTable meets you at the carotid bifurcation to discuss all things carotid angioplasty and stenting. Interventional neuroradiologist and cerebrovascular surgeon Dr. Adnan Siddiqui, Vice Chairman of the University of Buffalo’s Department of Neurosurgery, joins host Dr. Sameh Sayfo to discuss the evolution and current state of carotid disease treatment.

---

Get the BackTable app
https://www.backtable.com/app

---

This podcast is supported by

Terumo
https://www.terumois.com/

---

Timestamps

00:00 - Introduction
02:48 - From Aspirin to Endarterectomy
03:47 - Rise of Carotid Stenting
06:46 - CREST-2 and CMS Coverage
09:57 - Management of Severe Asymptomatic Carotid Stenosis
15:35 - New Stent Designs Explained
17:56 - Five Tips for New Operators
20:08 - Case Selection Algorithm
22:04 - Learning Curve and Mentorship
28:27 - What’s Next: IVL and Outpatient
31:24 - Managing Complications Safely
35:05 - Closing and Credits

---

More about this episode

Dr. Siddiqui details the history of carotid stenosis treatment, charting its path and progression from medical therapy to endarterectomy and modern stenting approaches. He includes how recent trial data and updated CMS reimbursements have influenced practice and generated recent developments such as second generation stent technology. Dr. Siddiqui shares perspectives on patient selection, operator learning curve, complication preparedness, and the importance of structured training and proctoring as technology and techniques continue to improve. The physicians close by overviewing future directions for the carotid space such as IVL and how to approach management of procedural complications.

---

Resources

Dr. Adnan Siddiqui provider profile
https://www.ubns.com/physicians/dr-adnan-h-siddiqui/

Carotid Endarterectomy for Asymptomatic Carotid Stenosis: Asymptomatic Carotid Surgery Trial (ACAS)
https://www.ahajournals.org/doi/10.1161/01.str.0000141706.50170.a7

Asymptomatic Carotid Surgery Trial (ACST-2)
https://www.acc.org/latest-in-cardiology/clinical-trials/2021/08/25/23/24/acst2

Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients (SAPPHIRE trial)
https://www.nejm.org/doi/full/10.1056/NEJMoa040127

Medical Management and Revascularization for Asymptomatic Carotid Stenosis (CREST-2 trial)
https://www.nejm.org/doi/full/10.1056/NEJMoa2508800

The North American Symptomatic Carotid Endarterectomy Trial (NASCET trial)
https://www.ahajournals.org/doi/10.1161/01.str.30.9.1751

Ep. 30 ECMO for Cardiologists: Practical Insights & Management with Dr. Allison Dupont

Tue, 24 Mar 2026 07:00:00 -0000

Understanding when to use extracorporeal membrane oxygenation (and how) can be extra complex, but knowing the intricacies of ECMO is key to using it effectively. In this episode of BackTable Cardiology, Dr. Hady Lichaa sits down with Dr. Allison Dupont to approach ECMO in a practical, clinically relevant way. They cover the fundamentals, including VV versus VA ECMO, circuit components, and key settings like flow, oxygenation, and CO2 removal.

---

Get the BackTable app
https://www.backtable.com/app

---

Timestamps

00:00 - Introduction
03:19 - What Is ECMO
12:19 - Who Should Get ECMO
16:12 - ECPR Criteria and Triage
29:45 - Access Strategy
32:43 - Low Flow Troubleshooting
44:24 - Anticoagulation Protocols
48:21 - Chugging Volume Alarms
50:25 - Weaning Off ECMO
55:22 - Building An ECMO Program

---

More about this episode

The conversation also dives into real-world application, including cannulation strategies, typical flow parameters, troubleshooting low flow, preventing limb ischemia, and managing anticoagulation. They explore advanced topics like LAVA-ECMO for valvular disease, ECPR protocols inspired by the ARREST Trial, and how to think about patient selection and “bridge” strategies. Dr. DuPont finishes with practical insights on weaning, LV unloading, bleeding management, and what it takes to successfully build an ECMO program with a multidisciplinary team.
---
Resources
Dr. Hady Lichaa’s Provider Profile
https://healthcare.ascension.org/find-care/provider/1336267533/hady-lichaa
Dr. Allison Dupont’s Provider Profile
https://northsidecvi.com/providers/our-cardiologists/allison-dupont
Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial
https://pubmed.ncbi.nlm.nih.gov/33197396/

Ep. 29 Radial Access for Peripheral Interventions: Techniques & Considerations with Dr. Shailendra Singh

Tue, 17 Mar 2026 07:00:00 -0000

Radial roots, peripheral reach! Radial to peripheral (R2P) access is the focus of this week’s episode with interventional cardiologist Dr. Shailendra Singh (Pennsylvania’s Lehigh Valley Heart and Vascular Institute) and dual hosts Hady Lichaa and Sameh Sayfo. The conversation focuses on key techniques, pre-procedure planning and imaging, and ideal case selection for those new to the R2P approach.

---

This podcast is supported by:

Terumo
https://www.terumois.com/

---

SYNPOSIS

Dr. Singh shares how he began incorporating radial-to-peripheral procedures into his practice after fellowship and how his experience with radial coronary access translated naturally to peripheral interventions. The group reviews access strategy, including right versus left radial selection, along with techniques for preventing and managing radial spasm. They also touch on staff workflow and training when introducing R2P into the lab. The episode closes with practical insights on case selection for operators new to the approach, the role of pedal access in selected CTO cases, and strategies for safe sheath removal and hemostasis.

---

TIMESTAMPS

00:00 - Introduction
04:42 - Radial-to-Peripheral: Right vs Left Radial
10:18 - Ultrasound and Pedal Access Applications
17:10 - Ideal Cases When Starting Radial to Peripheral
25:59 - Impactful Radial Success Stories
29:38 - Managing Radial Spasm
35:22 - Left Radial Workflow
42:00 - Shelf Setup Essentials
48:43 - Renal Mesenteric Access
55:37 - Safe Sheath Removal
01:01:10 - Training and Courses
01:04:48 - Closing Thoughts

---

RESOURCES

Dr. Shailendra Singh’s Provider Profile
https://www.lvhn.org/doctors/shailendra-singh

Dr. Sameh Sayfo’s Provider Profile
https://www.bswhealth.com/physician/sameh-sayf

Dr. Hady Lichaa’s Provider Profile
https://healthcare.ascension.org/find-care/provider/1336267533/hady-lichaa

Ep. 28 Understanding Manual and Mechanical Coronary Thrombectomy in Practice with Dr. Andrew Goldsweig

Tue, 10 Mar 2026 07:00:00 -0000

TAPAS, TASTE, TOTAL. These are the names of clinical trials that re-evaluated the use of manual aspiration thrombectomy in STEMI. In this episode of BackTable Cardiology, host Dr. Sameh Sayfo interviews Dr. Andrew Goldsweig, Director of Cardiovascular Clinical Research at Baystate Medical Center and Chair of the SCAI Standards and Guidelines Committee, about coronary thrombectomy in contemporary PCI.

---

This podcast is supported by an educational grant from Cheisi.

---

SYNPOSIS

Drs. Sayfo and Goldsweig review how evidence from major trials led to a Class III recommendation against routine manual aspiration thrombectomy in STEMI, discuss methodological differences among studies and concerns about stroke reporting, and clarify how selective or bailout use may still have a role in high thrombus-burden cases. Their conversation also covers growing interest in mechanical thrombectomy technologies, the design and limitations of newer device studies, practical considerations that influence adoption, and differing operator approaches to STEMI workflows. They conclude by discussing gaps in evidence, the need for comparative data, and potential future features of next-generation coronary thrombectomy devices.

---

TIMESTAMPS

00:00 - Introduction
02:51 - Manual vs Mechanical Thrombectomy
03:56 - TAPAS, TASTE, and TOTAL Trials
10:20 - CHEETAH Trial Breakdown
13:05 - Practice Patterns and Billing
16:26 - Step by Step STEMI Workflow
20:09 - Door to Balloon Reality
22:03 - Impella First Strategy
24:08 - High Thrombus Scenarios
33:30 - Wishlist Catheter Features

---

RESOURCES

Dr. Sameh Sayfo’s Provider Profile
https://www.bswhealth.com/physician/sameh-sayf

Dr. Andrew Goldsweig’s Provider Profile
https://www.baystatehealth.org/providers/andrew-m-goldsweig

A Prospective, Multicentre, Long-Term Cohort Study in Children, Adolescents and Adults with Seasonal Allergic Rhinitis-Design and Early Results (TAPAS)
https://pubmed.ncbi.nlm.nih.gov/40283440/

Thrombus Aspiration during ST-Segment Elevation Myocardial Infarction (TASTE)
https://www.nejm.org/doi/full/10.1056/NEJMoa1308789

Randomized Trial of Primary PCI with or without Routine Manual Thrombectomy (TOTAL)
https://www.nejm.org/doi/full/10.1056/NEJMoa1415098

CHEETAH Study by Penumbra
https://www.penumbrainc.com/cheetah-study-results/

Ep. 27 Enhancing Cardiology Practice Through Radiation Protection with Dr. Bob Foster

Tue, 03 Mar 2026 08:00:00 -0000

What do all image-guided interventionalists and surgeons have in common? Over time, the radiation exposure and the weight of lead begin to take a toll, often in ways no one talks about until it’s too late. In this episode of BackTable Cardiology, host Dr. Hady Lichaa sits down with Dr. Bob Foster, interventional cardiologist and Chief Medical Officer of Rampart IC, for a candid conversation about the hidden occupational risks facing today’s cath lab teams.

---

SYNPOSIS

Drawing on his extensive experience, he reflects on a career in complex coronary and peripheral intervention and the personal health crisis that forced him to confront the hidden dangers of operating in lead.
National survey data from the Society for Cardiovascular Angiography and Interventions (SCAI) reveal a sobering trend in orthopedic injury rates, prompting a deeper look at why meaningful change has been so slow. From workflow realities and emerging clinical data to advocacy efforts, this episode explores what it will take to truly move the needle on operator safety.

---

TIMESTAMPS

00:00 - Introduction
01:03 - The Lack of Progression for Radiation Protection
06:37 - Rampart’s Origin Story
14:24 - Evaluating the Data
23:28 - Workflow & Setup Time: Lab Practicalities
28:30 - Orthopedic Ergonomics
33:06 - Beyond Cardiology: Other Interventional Surgery Specialties
36:06 - Cost, ROI, and Legislation
41:54 - Making Advanced Shielding Practical and Affordable
50:46 - Protecting the Next Generation

---

RESOURCES

Dr. Hady Lichaa’s Provider Profile
https://healthcare.ascension.org/find-care/provider/1336267533/hady-lichaa

Dr. Bob Foster’s Provider Profile
https://www.doximity.com/pub/robert-foster-md-5201e3aa

Rampart IC
https://rampart.com

Ep. 26 Renal Denervation: Innovations in Hypertension Management with Dr. Eric Secemsky

Tue, 24 Feb 2026 08:00:00 -0000

John Doe is a 45 year-old male with a past medical history of hypertension, on high doses of amlodipine, metoprolol and lisinopril presenting to his cardiologist with a blood pressure of 165/86. He asks, “If the medications are not controlling my blood pressure, what are my options?” In this episode of the BackTable Cardiology Podcast, Dr. Sameh Sayfo sits down with Dr. Eric Secemsky, an internationally recognized interventional cardiologist and vascular medicine specialist to discuss renal denervation, a minimally invasive procedure that lowers blood pressure by disrupting overactive renal sympathetic nerves.

---

SYNPOSIS

From its proof of concept to the clinical trials that have shaped the current landscape, Drs. Sayfo and Secemsky dive into the intricacies of renal denervation. They explore the technical aspects of catheter-based denervation devices like Medtronic's Spyral catheter and Recor's Paradise device, discussing their procedures, safety features, and troubleshooting tips. The conversation also covers the significance of building advanced hypertension centers, the latest in renal denervation innovations, and the creation of a national registry to track procedural outcomes and enhance patient care.

---

TIMESTAMPS

00:00 - Introduction
02:52 - Guidelines Update: Why Renal Denervation Earned a Class 2B Recommendation
07:31 - Clinical Trials: What Went Wrong, What We Learned, and How Devices Improved
15:08 - Medtronic Symplicity Spyral
22:17 - ReCor Paradise
27:30 - Covering the Main Renal Artery: Anatomic Variants and Proximal Treatment Strategy
33:15 - Beyond Kidneys: Multi-Organ Denervation and Metabolic Effects
40:27 - Why Institutions Should Build Hypertension Centers

---

RESOURCES

Dr. Sameh Sayfo’s Provider Profile
https://www.bswhealth.com/physician/sameh-sayf

Dr. Eric Secemsky’s Provider Profile
https://findadoc.bidmc.org/details/3519

A Controlled Trial of Renal Denervation for Resistant Hypertension
https://www.nejm.org/doi/full/10.1056/NEJMoa1402670

Medtronic Symplicity Spyral™ Renal Denervation System
https://www.medtronic.com/en-us/healthcare-professionals/products/surgical-energy/ablation/radiofrequency-ablation/systems/symplicity-spyral-renal-denervation-system.html

SPYRAL GEMINI Pilot Study
https://clinicaltrials.gov/study/NCT06907147

Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities (NECTAR IV) Trial
https://clinicaltrials.gov/study/NCT05369065

Ep. 25 IVL & Atherectomy: Techniques for Complex PCI with Dr. Yousif Ahmad

Tue, 17 Feb 2026 08:00:00 -0000

How do imaging, intravascular lithotripsy, and equipment selection come together to effectively target coronary calcium? In this episode of BackTable, interventional cardiologists Dr. Robert Riley (Overlake Medical Center in Bellevue, Washington) and Dr. Yousif Ahmad (UCSF) trade techniques and discuss various aspects of calcium modification in complex percutaneous coronary intervention (PCI).

---

This podcast is supported by:

Shockwave Medical
https://shockwavemedical.com/

---

SYNPOSIS

The discussion begins with an overview of intravascular lithotripsy (IVL), including its mechanism of action, ideal lesion characteristics, and performance across varying calcium morphologies. The conversation then expands to comparative decision-making among atherectomy, specialty balloons, and IVL, emphasizing how intravascular imaging informs procedural planning and real-time optimization. Key clinical data are reviewed, including the Disrupt CAD I-IV series as well as findings from the Short-Cut and VICTORY trials. The episode concludes with a forward-looking discussion on emerging technologies and the ongoing challenge of treating calcified nodules, one of the most demanding substrates in coronary intervention.

---

TIMESTAMPS

00:00 - Introduction
04:16 - Complex PCI and Calcium Modification Tools
04:43 - Intravascular Lithotripsy (IVL) Insights and Evolution
12:08 - Calcium Modification Algorithms and Techniques
27:24 - IVUS vs. OCT Imaging and Specialty Balloons
32:12 - Challenges in Implementing New Techniques
37:09 - Influential Studies in Calcium Modification
40:52 - Recent Studies: Short-Cut and VICTORY
53:11 - Future of Calcium Modification Technologies
57:48 - Final Thoughts

---

RESOURCES

Dr. Robert Riley
https://www.scai.org/robert-f-riley-md-ms-fscai

Dr. Yousif Ahmad
https://profiles.ucsf.edu/yousif.ahmad

Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis
https://pubmed.ncbi.nlm.nih.gov/38401549/

Coronary intravascular lithotripsy for severe coronary artery calcification: The Disrupt CAD I-IV trials
https://www.sciencedirect.com/science/article/abs/pii/S1553838924000769

Orbital Atherectomy vs. Conventional Balloon Angioplasty in Severely Calcified Coronary Arteries Prior to DES Implantation - ECLIPSE
https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2024/10/25/04/32/eclipse

Shockwave Lithoplasty Compared to Cutting Balloon Treatment in Calcified Coronary Disease - A Randomized Controlled Trial (Short-Cut)
https://clinicaltrials.gov/study/NCT06089135

The Value of IVL Compared To OPN Non-Compliant Balloons for Treatment of RefractorY Coronary Lesions (VICTORY) Trial (VICTORY)
https://clinicaltrials.gov/study/NCT05346068

Ep. 24 Mitigating Orthopedic Strain and Radiation Effects: Best Practices in the Cath Lab with Dr. Sahil Parikh

Tue, 10 Feb 2026 08:00:00 -0000

This is a friendly reminder to unclench your jaw, sit up straight, and take a deep breath before diving into the latest episode of BackTable Cardiology! Host Dr. Sameh Sayfo from Baylor Scott & White Health speaks with Dr. Sahil Parikh, a renowned interventional cardiologist from Columbia University, about the health of interventional cardiologists. They discuss the various occupational hazards interventional cardiologists may be at risk for, particularly focusing on radiation exposure and orthopedic injuries caused by wearing lead aprons. The conversation touches on the need for better education and mandatory training for upcoming cardiologists to prevent such injuries.

---

SYNPOSIS

As Dr. Parikh shares his personal experiences with orthopedic issues related to the extensive use of lead protection, he highlights the importance of radiation safety and advocates for incorporating advanced protective technologies in the labs. Dr. Sayfo and Dr. Parikh also discuss the significant trials presented at TCT 2025, their potential impact on clinical practice, and the importance of advocacy by societies like SCAI and the American College of Cardiology (ACC) in improving interventional cardiologists' working conditions.

---

TIMESTAMPS

00:00 - Introduction
01:58 - Orthopedic Issues in Interventional Cardiology
04:00 - The Impact of Wearing Lead
13:06 - Ergonomics and Risk Factors
15:47 - Preventative Measures and Solutions
23:22 - The Role of Medical Societies
27:00 - Radiation Reduction Devices Overview
30:57 - Barriers to Adopting Safety Technologies
35:40 - Addressing Burnout in Interventional Cardiology
42:06 - Highlights from TCT 2025

---

RESOURCES

Dr. Sahil Parikh Provider Profile
https://doctors.columbia.edu/us/ny/new-york/sahil-a-parikh-md-161-fort-washington-avenue

Dr. Sameh Sayfo Provider Profile
https://www.bswhealth.com/physician/sameh-sayfo

Cardiovascular Research Foundation's Transcatheter Cardiovascular Therapeutics (CRF TCT) Conference 2025 - The Global Forum for Interventional Cardiology
https://www.tctconference.com/

Society for Cardiovascular Angiography & Interventions
https://www.scai.org/

American College of Cardiology
https://www.acc.org/

Ep. 23 Understanding DEB in Coronary Interventions: Techniques & Outcomes with Dr. Mohammad Alkhalil and Dr. Abhishek Kumar

Tue, 03 Feb 2026 08:00:00 -0000

Are drug-eluting balloons (DEBs) the best way to treat in-stent restenosis? In this episode of BackTable Cardiology, host and interventional cardiologist Dr. Sameh Sayfo takes a closer look at the evolving applications of coronary DEBs with two esteemed guests from the UK, Dr. Mohammad Alkhalil and Dr. Abhishek Kumar.

---

SYNPOSIS

This conversation covers the history and application of DEBs in treating in-stent restenosis (ISR) and small vessel disease, the differences between paclitaxel and limus-based drugs, the importance of lesion preparation and imaging, and the future potential of DEBs in coronary interventions. Dr. Kumar elaborates on the LOVE DEB study, which is investigating the use of DEBs in large de novo vessels, while Dr. Alkhalil shares his experiences and insights on adapting DEB technology in various clinical scenarios, including bifurcation lesions and acute myocardial infarction. The episode emphasizes the current role of DEB technology while cautioning against a reckless approach to its application.

---

TIMESTAMPS

00:00 - Introduction
02:34 - Historical Perspective and Key Studies on DCB
06:30 - Mechanisms and Imaging in In-Stent Restenosis
11:39 - Comparing Paclitaxel and Limus DCBs
13:24 - Choosing the Right DCB: Factors and Preferences
17:23 - DCB in Complex Cases: Bifurcations and Beyond
24:01 - Challenges and Adoption of DCB in Europe
27:38 - The Role of Imaging in DCB Procedures
30:13 - Insights from the LOVE DEB Study
38:59 - Future Directions in DCB Technology

---

RESOURCES

Dr. Sameh Sayfo Provider Profile
https://www.bswhealth.com/physician/sameh-sayfo

LOVE DEB Clinical Trial
https://clinicaltrials.gov/study/NCT05915468

The European Bifurcation Club Left Main Coronary Stent Study: A Randomized Comparison of Stepwise Provisional vs. Systematic Dual Stenting Strategies (EBC MAIN)
https://pubmed.ncbi.nlm.nih.gov/34002215/

Ep. 22 The Role of Cangrelor in Modern Interventional Cardiology: Practice, Guidelines, & Data Review with Dr. Roxana Mehran

Tue, 27 Jan 2026 08:00:00 -0000

Fast acting and reversible: IV cangrelor offers rapid on, rapid off P2Y12 platelet inhibition that sidesteps oral absorption delays. In this episode of the BackTable Cardiology Podcast, host Dr. Sameh Sayfo welcomes renowned interventional cardiologist Dr. Roxana Mehran, incoming President elect of the American College of Cardiology (ACC), to discuss the emerging role of cangrelor and its implications on current cardiology practice.

---

This podcast is supported by an educational grant from Cheisi.

---

SYNPOSIS

Dr. Mehran and Dr. Sayfo cover the history and outcomes of the CHAMPION PHOENIX trial, cangrelor’s adoption and underutilization, and the nuances of transitioning high acuity patients between IV and PO antiplatelet therapies. Dr. Mehran also addresses the role of gender in cardiovascular health and the importance of inclusive representation in clinical studies. The episode concludes with Dr. Mehran sharing her initiatives to support women and minorities in cardiology, including her work as co-founder of Women As One.

---

TIMESTAMPS

00:00 - Introduction to the BackTable Podcast
01:57 - Understanding Cangrelor and Its Impact
02:18 - CHAMPION PHOENIX Study Insights
07:02 - Challenges and Misconceptions of Cangrelor in Cardiogenic Shock and STEMI
14:41 - Antiplatelet Bridging to Surgery and Gender Differences in Treatment
17:39 - The SMILE Study and Real-World Applications
20:49 - Advancing Women in Cardiology
29:22 - Future of Interventional Cardiology
32:53 - Holistic Cardiac and Vascular Health
36:01 - Conclusion and Final Thoughts

---

RESOURCES

Dr. Roxana Mehran:
https://profiles.mountsinai.org/roxana-mehran

Dr. Sameh Sayfo:
https://www.bswhealth.com/physician/sameh-sayfo

Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events (CHAMPION PHOENIX Trial):
https://www.nejm.org/doi/full/10.1056/NEJMoa1300815

Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition – CHAMPION Platform Clinical Trial
https://www.clinicaltrials.gov/study/NCT00385138

Intravenous Platelet Blockade with Cangrelor during PCI (CHAMPION PCI):
https://www.nejm.org/doi/full/10.1056/NEJMoa0908629

Meta-Analysis of the Role of Cangrelor for Patients Undergoing Percutaneous Coronary Intervention
https://www.sciencedirect.com/science/article/abs/pii/S0002914919300426

Timing, indications and transition patterns associated with cangrelor use in patients undergoing PCI
https://pubmed.ncbi.nlm.nih.gov/40813532/

Women As One
https://womenasone.org/about/

Ep. 21 Current HFpEF Treatments: Clinical Pearls & Progress with Dr. Jessica Huston

Tue, 20 Jan 2026 08:00:00 -0000

If your New Year’s resolution involves learning more about current practice guidelines and emerging research on Heart Failure with Preserved Ejection Fraction (HFpEF), you’re in the right place! In this episode of the BackTable Cardiology Podcast, host Dr. Hady Lichaa welcomes heart failure specialist Dr. Jessica Huston to provide a practical update on managing heart failure with preserved ejection fraction (HFpEF).

---

SYNPOSIS

Dr. Huston and Dr. Lichaa discuss the complexity of diagnosing HFpEF, differences between HFpEF and diastolic heart failure, phenotypes within HFpEF, and treatment strategies, including the use of aldosterone blockers, SGLT-2 inhibitors, and GLP-1 agonists. Dr. Huston emphasizes the importance of phenotyping patients for accurate diagnosis and treatment, and discusses the potential of future therapies and devices. Their conversation also covers the role of inflammation, metabolic syndrome, and the challenges faced in managing fluid balance and hypertension in HFpEF patients.

---

TIMESTAMPS

00:00 - Introduction
02:20 - Understanding HFpEF
05:23 - Phenotypes and Treatment Approaches
06:29 - Metabolic Syndrome and HFpEF
09:17 - Emerging Treatments and Clinical Trials
11:36 - Medication Strategies and Challenges
24:51 - Diuretics and Their Limitations
31:35 - Advanced Diuretic Strategies
35:37 - Hemodynamic Measurements and Their Implications
40:02 - Coronary Disease and HFpEF
42:52 - Future Directions in Heart Failure Treatment
45:45 - Device Therapies and Patient Management
49:39 - Concluding Thoughts and Future Prospects

---

RESOURCES

Dr. Jessica Huston Provider Profile
https://healthcare.ascension.org/find-care/provider/1073874616/jessica-huston

Dr. Hady Lichaa Provider Profile
https://healthcare.ascension.org/find-care/provider/1336267533/hady-lichaa

The SUMMIT Trial
https://pubmed.ncbi.nlm.nih.gov/39555826/

The TOPCAT Trial
https://pubmed.ncbi.nlm.nih.gov/24716680/

The FINEARTS Trial
https://pubmed.ncbi.nlm.nih.gov/39225278/

The CADENCE Trial
https://www.clinicaltrials.gov/study/NCT04945460

Ep. 20 System Innovations in Medical Practice with Dr. Mohamad Alkhouli

Tue, 13 Jan 2026 08:00:00 -0000

Clinicians play a central role in shaping cardiovascular innovation, yet many lack a clear pathway to participate. In this episode of BackTable Cardiology, Dr. Sameh Sayfo speaks with Dr. Mohamad Alkhouli, cardiologist and Chair of Research and Innovation at the Mayo Clinic, about practical approaches for clinician involvement in healthcare innovation and strategies to address persistent gaps in cardiovascular care access.

---

SYNPOSIS

The discussion examines Dr. Alkhouli’s decision to pursue an MBA, the role of business and organizational training in medical leadership, and how system-level thinking informs innovation beyond device development. Broader themes include stakeholder alignment, organizational behavior, and emerging opportunities for non-device innovation within contemporary cardiovascular practice.

---

TIMESTAMPS

00:00 - Introduction
01:49 - The Value of an MBA for Physicians
05:24 - Understanding Systems and Organizational Behavior
07:31 - Navigating Innovation in MedTech
13:15 - Bridging the Gap Between Physicians and Business
19:44 - The Role of Professional Societies in Innovation
25:32 - Future Trends in Interventional Cardiology
29:58 - Global Perspectives on Innovation
31:47 - Closing Remarks and Credits

---

RESOURCES

American College of Cardiology
https://www.acc.org/

Bolt Medical Acquisition
Boston Scientific Announces Agreement to Acquire Bolt Medical, Inc.

Silk Road Medical Acquisition
Boston Scientific Closes Acquisition of Silk Road Medical, Inc.

Dr. Mohamad Alkhouli’s Provider Profile https://www.mayoclinic.org/biographies/alkhouli-mohamad-m-d-m-b-a/bio-20465257

Dr. Sameh Sayfo’s Provider Profile
https://www.bswhealth.com/physician/sameh-sayfo

Ep. 19 Intravenous Antiplatelet Therapy in Acute Coronary Syndrome with Dr. Hayder Hashim

Tue, 06 Jan 2026 08:00:00 -0000

Preventing problems before they aggregate, P2Y12 inhibitor style! In this episode of the BackTable Cardiology Podcast, interventional cardiologist from MedStar Washington Hospital Center joins host Dr. Hady Lichaa for practical insights and key takeaways on antiplatelet use in the setting of acute coronary syndrome (ACS).
---
This podcast is supported by an educational grant from Cheisi.
---
SYNPOSIS
Dr. Hashim talks through the use of intravenous antiplatelet therapies, specifically cangrelor, for managing acute coronary syndrome. Their discussion explores the pharmacokinetics, clinical advantages, and potential future applications of IV P2Y12 inhibitors. Dr. Hashim shares his wealth of experience in antiplatelet case studies and shares best practices when transitioning patients from IV to oral antiplatelet therapies. The conversation focuses on enhancing patient outcomes, minimizing complications, and lessons learned from different clinical scenarios.
---
TIMESTAMPS
00:00 - Introduction
03:31 - Intravenous Antiplatelet Therapies Overview
06:01 - The Importance of IV P2Y12 Inhibitors
09:15 - Guidelines and Usage of GP IIb/IIIa Inhibitors
11:30 - Advantages of IV P2Y12 Inhibitors in Clinical Practice
14:32 - Practical Applications and Case Studies
24:42 - Cost Effectiveness, Hospital Administration, Financial Implications
28:20 - Contraindications and Practical Considerations
30:09 - Loading and Infusion Protocols
34:58 - Bridging for Surgery
39:48 - Anticoagulation and Heparin Goals
48:55 - Future of IV Antiplatelet Therapy
50:44 - Conclusion
---
RESOURCES
Association of 2B3A inhibition with new antiplatelet regimens in the setting of acute coronary syndromes: a meta-analysis of randomized controlled trials
https://academic.oup.com/eurheartj/article-abstract/34/suppl_1/P4861/2862796
Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events - CHAMPION PHOENIX
https://www.nejm.org/doi/full/10.1056/NEJMoa1300815
Morphine for treatment of cough in idiopathic pulmonary fibrosis (PACIFY COUGH): a prospective, multicentre, randomised, double-blind, placebo-controlled, two-way crossover trial
https://pubmed.ncbi.nlm.nih.gov/38237620/
Abstract 4370674: Cangrelor Versus Oral P2Y12 Inhibitors During PCI in Cardiogenic Shock and Cardiac Arrest: A Systematic Review and Meta-analysis
https://www.ahajournals.org/doi/10.1161/circ.152.suppl_3.4370674
Dr. Hayder Hashim
https://www.medstarhealth.org/doctors/hayder-hashim-md
Dr. Hady Lichaa
https://healthcare.ascension.org/find-care/provider/1336267533/hady-lichaa

Ep. 18 The Role of Minimally Invasive Robotic Cardiac Surgery in Modern Cardiology Practice with Dr. Amber Edwards

Tue, 30 Dec 2025 08:00:00 -0000

From sternotomy to software, the booming field of robotic cardiac surgery is bringing new minimally invasive treatment approaches to well-traveled cardiology conditions. This week on the BackTable Cardiology Podcast, Dr. Amber Edwards, a distinguished cardiothoracic surgeon from Ascension St. Thomas in Nashville, shares her expertise in robotic cardiac surgery with host and Tennessee neighbor Dr. Hady Lichaa. The two physicians discuss the growth and technical advancements within robotic cardiac surgery, including the burgeoning field of hybrid revascularization.

---

SYNPOSIS

Dr. Edwards outlines her journey in the cardiothoracic field, sharing her experiences with pioneers of minimally invasive and robotic cardiac surgeries. The discussion explores various procedures, including totally endoscopic coronary artery bypass (TECAB), minimally invasive direct coronary artery bypass (MIDCAB), and robotic LIMA to LAD bypass. Dr. Edwards also elaborates on robotic left atrial appendage ligations, robotic mitral and aortic valve surgeries, and conversion procedures for atrial fibrillation, highlighting their technical challenges, patient selection, and potential for broader adoption.

---

TIMESTAMPS

00:00 - Introduction
03:33 - MIDCAB and TECAB Procedures
07:11 - Preoperative Testing and Considerations
09:09 - Challenges and Complexities in Robotic Surgery
17:20 - Hybrid Revascularization and Antiplatelet Therapy
26:02 - The Future and Adoption of Robotic Surgery
30:56 - Exploring Robotic Left Atrial Appendage Ligation
32:03 - The Convergent Procedure for AFib Patients
40:56 - Robotic Mitral Valve Surgery: Techniques and Benefits
47:11 - The Future of Robotic Cardiac Surgery
50:20 - Conclusion

---

RESOURCES

Dr. Amber Edwards
https://healthcare.ascension.org/find-care/provider/1699031591/amber-edwards

Dr. Hady Lichaa
https://healthcare.ascension.org/find-care/provider/1336267533/hady-lichaa

REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women (RECHARGE:W)
https://clinicaltrials.gov/study/NCT06399692

Ep. 17 Update in Intravascular Imaging for Optimal PCI with Dr. Erik Rafflenbeul

Tue, 16 Dec 2025 08:00:00 -0000

Intravascular imaging can provide invaluable intel on the coronaries, with OCT supplying bright ideas and IVUS giving sound judgement. Light-based and soundwave-based, respectively, mastery of these two imaging modalities can help you streamline routine PCI cases and overcome challenging ones. In this episode of BackTable Cardiology, the esteemed Dr. Erik Rafflenbeul from Schön Klinik in Hamburg, Germany joins host Dr. Hady Lichaa from Tennessee’s Ascension St. Thomas Heart to discuss intravascular imaging techniques for percutaneous coronary interventions.

---

SYNPOSIS

The conversation covers a wide range of topics, including the importance and benefits of using intravascular imaging, the differences and applications of intravascular ultrasound (IVUS) and optical coherence tomography (OCT) systems, recent intravascular clinical studies to know, and practical aspects of integrating these technologies into daily practice. Dr. Rafflenbeul emphasizes the value of proactive imaging and shares comprehensive insights for both seasoned and early-career interventional cardiologists.

---

TIMESTAMPS

00:00 - Introduction
03:52 - Current State of Intravascular Imaging in Germany and Europe
05:26 - Importance of Intravascular Imaging in PCI
09:08 - Challenges and Adoption of Intravascular Imaging
13:30 - IVUS vs. OCT: Which to Choose?
17:06 - Practical Insights on IVUS and OCT Systems
28:50 - Pre-Procedural Measurements and Techniques
30:36 - Choosing Stent Diameters
32:22 - Practical Aspects of Stenting
36:40 - Post-PCI Assessment and Algorithm
40:35 - Recent Intravascular Imaging Studies
43:07 - Case Studies and Practical Tips
47:16 - Advice for Early Career Interventionalists
51:54 - Concluding Thoughts and Wisdom

---

RESOURCES

Dr. Hady Lichaa
https://healthcare.ascension.org/find-care/provider/1336267533/hady-lichaa

Dr. Erik Rafflenbeul
https://www.pcronline.com/Physicians/Erik-Rafflenbeul

European Association of Percutaneous Cardiovascular Interventions (EAPCI)
https://www.escardio.org/Sub-specialty-communities/European-Association-of-Percutaneous-Cardiovascular-Interventions-%28EAPCI%29#

Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease
https://www.jacc.org/doi/10.1016/j.jacasi.2022.12.009#:~:text=The%20OPTIVUS%20(Optimal%20IntraVascular%20Ultrasound)%2DComplex%20PCI%20study,infarction%20*%20Stroke%20*%20Any%20coronary%20revascularization

Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)02454-6/abstract

A Revised Optical Coherence Tomography–Derived Calcium Score to Predict Stent Underexpansion in Severely Calcified Lesions
https://www.sciencedirect.com/science/article/abs/pii/S193687982401817X#:~:text=Lesions%20with%20severe%20calcium%20as,higher%20risk%20for%20stent%20underexpansion.

Intravascular Imaging vs Angiography Guidance for PCI of Severely Calcified Lesions: The ECLIPSE Trial
https://pubmed.ncbi.nlm.nih.gov/41093451/#:~:text=The%20primary%20clinical%20outcome%20was,tomographic%20guidance%20and%20IVUS%20guidance.

Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents - ADAPT-DES
https://www.acc.org/latest-in-cardiology/clinical-trials/2012/10/25/11/12/adapt-des

Ep. 16 The Evolution of TAVR: Historical Insights & Future Innovations with Dr. Michael Mack

Tue, 09 Dec 2025 08:00:00 -0000

Transcatheter aortic valve replacement (TAVR) may be a standard cardiac procedure today, but its origin story follows an intriguing tale of courage, innovation and heart. In this episode of BackTable Cardiology, renowned cardiothoracic surgeon Dr. Michael Mack, a global leader in structural heart disease from Baylor Scott White Health, shares the history of TAVR, highlighting its origins, key clinical trials, and the eventual success of TAVR as a primary therapy.

---

SYNPOSIS

Dr. Michael Mack and host Dr. Sameh Sayfo discuss the early adaptations, challenges, and adoption of TAVR, detailing the collaborative efforts amongst medical professionals that led to its widespread utilization. They also explore the future of valve technology and the importance of multidisciplinary teamwork in advancing cardiovascular care. The discussion concludes with insights into emerging heart technologies and the evolving partnership between different medical specialties.

---

TIMESTAMPS

00:00 - Introduction
02:27 - Inception of TAVR
03:01 - The Global Reach of TAVR
11:10 - Placement of Aortic Transcatheter Valves (PARTNER) Trial
19:10 - Advancements in Cardiac Imaging
20:35 - Mapping the Next Five Years
23:20 - Strides in Aortic Insufficiency
25:16 - Collegiality in Cardiac Care

---

RESOURCES

How Transcatheter Aortic Valve Implantation (TAVI) Was Born: The Struggle for a New Invention
https://pmc.ncbi.nlm.nih.gov/articles/PMC8511628/

Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
https://www.nejm.org/doi/full/10.1056/NEJMoa1008232

Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years
http://nejm.org/doi/full/10.1056/NEJMoa2307447

Dr. Michael Mack Provider Profiles
https://news.bswhealth.com/en-US/photos/michael-mack-md

Dr. Sameh Sayfo Provider Profile
https://www.bswhealth.com/physician/sameh-sayfo

Ep. 15 Evolving Approaches in PE Management with Dr. Sabah Butty

Tue, 02 Dec 2025 08:00:00 -0000

When there's something strange in your vasculature, who are you going to call? Clot busters! In this episode of the BackTable Podcast, interventional cardiologist Dr. Sameh Sayfo hosts interventional radiologist Dr. Sabah Butty from Indiana University to discuss contemporary interventional approaches to pulmonary embolism (PE).

---

This podcast is supported by:

Angiodynamics
https://www.angiodynamics.com/

---

SYNPOSIS

Dr. Butty shares his extensive experience in managing venous thromboembolism (VTE) and pulmonary embolism, highlighting the evolution of treatment strategies over the past 15 years. The discussion covers the shift from catheter-directed thrombolysis (CDT) to large bore mechanical thrombectomy, the importance of understanding the disease process, the efficiency and effectiveness of various devices–including the Alpha Vac–and the importance of achieving both short-term and long-term efficacy. Dr. Butty also shares insights on post-procedure management and follow-up protocols for PE patients.

---

TIMESTAMPS

00:00 - Introduction
02:53 - Development of AMI, Stroke and VTE Management
07:52 - Device Selection
04:25 - The Shift in Mechanical and Medicinal Therapies
13:23 - The Alpha Vac Device
16:50 - Benefits of Using Alpha Vac Device
20:26 - Considerations for Blood Loss During Procedure
24:30 - End of Case Criteria for Thrombectomy
28:24 - Post Procedure Follow-Up

---

RESOURCES

Dr. Sameh Sayfo Provider Profile
https://www.bswhealth.com/physician/sameh-sayfo

Dr. Sabah Butty Provider Profile
https://iuhealth.org/find-providers/provider/sabah-d-butty-md-5216

Prospective Multicenter IDE Study of the Next-Generation Precision Aspiration Thrombectomy System for Intermediate-Risk Pulmonary Embolism: The SYMPHONY-PE Trial
https://www.ahajournals.org/doi/full/10.1161/CIRCINTERVENTIONS.125.015815

Ep. 14 COSIRA II: Refractory Angina Challenges & Treatment Strategies with Dr. Jai Khatri and Dr. Ziad Ali

Tue, 11 Nov 2025 08:00:00 -0000

Sham-controlled, randomized, and double-blind: the COSIRA II trial has the makings to make big waves in the management of refractory angina. This week’s episode features two interventionalists that are well-versed in coronary sinus reducers and the trials investigating them. Dr. Ziad Ali, from St. Francis Hospital and Heart Center in New York, and Dr. Jai Khatri, with Weill Cornell Medicine, join BackTable Cardiology to discuss the challenges and potential solutions in treating refractory angina in interventional cardiology.

---

This podcast is supported by:

Shockwave Reducer
https://shockwavemedical.com/clinical-evidence/cosira-ii/

---

SYNPOSIS

The doctors cover the current approaches to managing chronic angina before and after PCI, discuss how to differentiate ischemic heart disease from non-ischemic chest pain, and address the burdens faced by patients with complex atherosclerotic disease. A significant focus of the episode is on the role of the coronary sinus reducer, including procedure technique, risks, benefits, and its potential for treating both obstructive coronary artery disease and microvascular disease. The doctors also explore the logistics and challenges of enrolling patients in the COSIRA-II trial and speculate on the future impact of this device in clinical practice.

---

TIMESTAMPS

00:00 - Introduction
01:42 - Understanding Refractory Angina
03:36 - Diagnostic Approaches
06:32 - Medical Therapy for Angina
10:29 - Complex Cases and Treatment Strategies
18:00 - Coronary Sinus Reducer
27:11 - Understanding the Risks and Learning Curve
28:06 - The COSIRA II Trial
30:27 - Tips for Patient Recruitment and Management
33:05 - Handling Treadmill Tests and Patient Communication
38:10 - Referral Patterns and Inter-Institutional Collaborations
45:38 - Future of Coronary Sinus Reducer
50:33 - Final Thoughts

---

RESOURCES

Dr. Ziad Ali
https://ziadalimd.com/

Dr. Jai Khatri
https://doctors.nyp.org/jaikirshan-khatri-md/cardiology-weill-greenberg-center

COSIRA Trial
https://www.nejm.org/doi/full/10.1056/NEJMoa1402556

COSIRA II Trial
https://clinicaltrials.gov/study/NCT05102019

Ep. 13 Percutaneous Tricuspid Interventions: Repair & Replacement Approaches with Dr. Joe Walsh and Dr. Aidan Raney

Tue, 04 Nov 2025 08:00:00 -0000

Tricuspid valve repair has seen booming growth in the interventional arena in the last five years, and the trajectory is only up from here. In this episode, interventional cardiologists Dr. Joe Walsh and Dr. Aiden Raney share their wealth of insights and experiences with the latest advancements in tricuspid interventions.

---

SYNPOSIS

The conversation covers recent landmark trials, relevant tricuspid physiology, and hands-on experiences in the cath lab with specialty devices like TriClip and Evoque. The interventionalists discuss patient selection, including how to distinguish which patients are most likely to benefit from intervention and how to define procedural success. Dr. Walsh and Dr. Raney also highlight the educational opportunities provided by MurmurMD, a specialized social media platform for peer-to-peer learning for cardiologists and cardiac surgeons.

---

TIMESTAMPS

00:00 - Introduction
01:29 - Tricuspid Valve Interventions: An Overview
03:55 - Understanding Tricuspid Regurgitation
10:29 - Therapeutic Options for the Tricuspid Valve
29:25 - Evaluating Success Rates and Patient Expectations
32:27 - Right Heart Catheterization
33:04 - Patient Selection Criteria
34:18 - Challenges with Tricuspid Valve Procedures
34:31 - Case Study: Evoke Device Size Variation
35:26 - Impact of Tricuspid Annulus Rigidity
37:57 - Complications and Management in Tricuspid Procedures
50:00 - Financial Considerations and Reimbursement
54:17 - Training and Educational Resources
59:49 - Conclusion and Final Thoughts

---

RESOURCES

Dr. Aidan Raney
https://www.providence.org/doctors/interventional-cardiology/az/phoenix/aidan-raney-1962631101

Dr. Joe Walsh
https://www.saintalphonsus.org/provider/joe-walsh

Coapt Study
https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2018/09/21/20/12/COAPT

Triluminate Study:
https://www.nejm.org/doi/full/10.1056/NEJMoa2300525

Triscend Study:
https://www.nejm.org/doi/full/10.1056/NEJMoa2401918

Ep. 12 The State of Coronary DEB Technology in the USA with Dr. Ron Waksman

Tue, 28 Oct 2025 07:00:00 -0000

Coronary drug-eluting balloon technology continues to evolve, but has its utilization been stunted by stenting? In this episode, Dr. Sameh Sayfo, an interventional cardiologist, hosts Dr. Ron Waksman, an internationally recognized cardiologist and scientist, to discuss advancements in coronary interventions and the age-old question of which coronary revascularization tools to use in which clinical scenarios.
---
SYNPOSIS
Dr. Waksman shares his 30-year journey in the field, detailing the history and transition from traditional balloon angioplasty to drug-eluting stents, and now to drug-coated balloons. They explore the benefits and challenges of each technology, the significance of vessel preparation, and the latest trials, including the De Novo Trial led by Dr. Waksman. The conversation also touches on the importance of physician education and proper training in adopting new technologies. Additionally, Dr. Waksman provides insights into his approach to conducting interviews with notable public figures and hints at future discussions at the CRT annual meeting, potentially featuring President Biden.
---
TIMESTAMPS
00:00 - Introduction
03:40 - The History of Drug-Eluting Stents
07:25 - Vessel Preparation To Ensure Good Balloon Angioplastic Technique
10:36 - Bioabsorbable Scaffolds
14:57 - The AGENT IDE Randomized Clinical Trial
20:16 - The Use of Paclitaxel Versus Sirolumus in Drug-Eluting Stents
29:40 - Cardiovascular Research Technologies (CRT) Annual Meeting
31:02 - Advice for Early Stage Colleagues
---
RESOURCES
Dr. Sameh Sayfo:
https://www.bswhealth.com/physician/sameh-sayfo
Dr. Ron Waksman
https://www.medstarhealth.org/doctors/ron-waksman-md
De Novo Trial, Drug-Coated Balloon for De Novo Coronary Artery Disease: Journal of American College of Cardiology State-of-the-Art Review
https://pubmed.ncbi.nlm.nih.gov/32138967/
The AGENT IDE Randomized Clinical Trial, Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis: The AGENT IDE Randomized Clinical Trial
https://pubmed.ncbi.nlm.nih.gov/38460161/

Ep. 11 PERT Consortium Recap: New Developments in PE with Dr. Jonathan Paul and Dr. Osman Ahmed

Fri, 24 Oct 2025 07:00:00 -0000

PERT Consortium 2025 gives interventionalists the reins to tackle even the toughest saddle pulmonary embolisms. In this episode of the BackTable Podcast, host Dr. Aaron Fritts welcomes interventional radiologist Dr. Osman Ahmed and interventional cardiologist Dr. Jonathan Paul to discuss their experiences at the annual PERT Consortium in San Diego, and offer their perspectives on the latest developments in pulmonary embolism (PE) treatment.

---

SYNPOSIS

The doctors delve into advancements and trials within the PE treatment space, including new devices and clinical studies that are set to shape the future of pulmonary embolism care. The conversation highlights the value of collaboration between interventional specialties, the safety and efficacy of various PE interventions, and the growing trend of using combined therapies. They also provide updates on their ongoing innovation with Flow Medical, describing their philosophy and motivation for developing a new device for PE treatment that incorporates real-time pulmonary artery pressures, mean systolic and diastolic pressures, and a potential for AI utilization in the future.

---

TIMESTAMPS

00:00 - Introduction
01:23 - PERT Consortium Highlights
02:11 - Emerging Clinical Trials and Innovations
03:59 - Thrombectomy Devices and Market Trends
12:37 - Flow Medical: Origin and Updates
19:37 - Advanced Data Tracking in Cardiology
20:45 - Remote Monitoring and Mobile Integration
22:45 - Cardiologists’ Data-Driven Approach
23:10 - Upcoming Studies and Data Insights
24:10 - Interventional Radiology and Cardiology Collaboration
25:07 - Access to Care and Procedure Adoption
27:32 - Final Thoughts

---

RESOURCES

Pulmonary Embolism Response Team (PERT) Consortium
https://pertconsortium.org/

Flow Medical
https://www.flowmedical.co/

PEERLESS RCT
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.124.072364

RESCUE-II
https://www.jacc.org/doi/10.1016/j.jacadv.2025.101789

PEERLESS II
https://www.jscai.org/article/S2772-9303(24)01053-6/fulltext

Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy (PE-TRACT)
https://clinicaltrials.gov/study/NCT05591118

The HI-PEITHO Study
https://www.bostonscientific.com/en-EU/medical-specialties/vascular-surgery/venous-thromboembolism-portal/pulmonary-embolism/clinical-data/hi-peitho.html

PRAGUE-26
https://eurointervention.pcronline.com/article/design-and-rationale-of-prague-26-a-multicentre-randomised-trial-of-catheter-directed-thrombolysis-for-intermediate-high-risk-acute-pulmonary-embolism

Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy (PE-TRACT)

https://clinicaltrials.gov/study/NCT05591118

Aaron Fritts, MD
https://www.backtable.com/shows/vi/contributors/dr-aaron-fritts

Osman Ahmed, MD
https://jointvascular.com/team/osman-ahmed-m-d-fcirse/

Jonathan Paul, MD
https://www.uchicagomedicine.org/find-a-physician/physician/jonathan-d-paul

Ep. 10 Intracardiac Echocardiography in Structural Heart Disease with Dr. Karim Al-Azizi

Tue, 21 Oct 2025 07:00:00 -0000

Real intracardiac echo cases, real-time developments! In this episode of BackTable Cardiology, host Dr. Sameh Sayfo is joined by Dr. Karim Al-Azizi, a structural interventional cardiologist at Baylor Scott & White Heart Hospital Plano. Together, they explore the evolving role of intracardiac echocardiography (ICE) through three real cases of ICE use in structural heart interventions. Join as they walk through patient profiles, imaging strategies, and clinical outcomes from ICE-guided cases.

---

SYNPOSIS

Dr. Al-Azizi shares his journey into the field of structural heart disease, highlighting the practical benefits and challenges of ICE and describing how it is transforming procedural guidance and patient outcomes. The episode concludes with a discussion on the Dallas PCI conference, emphasizing practical, hands-on learning for physicians.

---

TIMESTAMPS

00:00 - Introduction

02:46 - Advancements in Structural Heart Procedures

05:38 - Intracardiac Echocardiography (ICE) Explained

09:27 - Practical Applications of ICE

13:53 - Learning and Training in ICE

17:22 - Comparing ICE Technologies

22:38 - Case Studies: ICE in Action

43:54 - Dallas PCI Conference and Closing Remarks

---

RESOURCES

Dr. Karim Al-Azizi
https://www.bswhealth.com/physician/karim-al-azizi

Dr. Sameh Sayfo
https://www.bswhealth.com/physician/sameh-sayfo

Baylor Scott & White Heart Hospital Plano
https://www.bswhealth.com/the-heart-hospital/locations/plano

ICE Overview
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.117.031343

ICE Use in SVT and Afib
https://pmc.ncbi.nlm.nih.gov/articles/PMC11270097/

ICE Use in Left Atrial Appendage
https://pmc.ncbi.nlm.nih.gov/articles/PMC12209866/

Ep. 9 Coronary Atherectomy: Indications, Techniques & Device Selection with Dr. Wissam Jaber

Tue, 14 Oct 2025 07:00:00 -0000

What coronary device do you reach for when a blockage won’t budge? In this episode of the BackTable Cardiology Podcast, Dr. Wissam Jaber from Emory University Hospital joins host Dr. Hady Lichaa to discuss the intricacies of coronary atherectomy, outlining the differences between rotational and orbital atherectomy, their indications, and their technical nuances.
---
SYNPOSIS
Dr. Jaber shares his experiences with both rotational and orbital atherectomy, when he uses which for specific lesion subsets, potential complications, and strategies to manage them. This episode provides essential insights for cardiologists seeking to enhance their proficiency in managing calcified coronary lesions.
---
TIMESTAMPS
00:00 - Introduction
04:39 - Use of Lasers in Atherectomy
07:12 - Determining Guide and Catheter Size
14:24 - Laser Contrast Mix
17:15 - Perforation Detection and Management
25:16 - Treating the Circumflex Ostium
32:17 - Using a Guide Extension Catheter with Atherectomy Devices
36:36 - Orbital Versus Rotational Atherectomy
47:21 - Navigating Tortuosity in Atherectomies
52:45 - Complications (Perforations, Dissections and Distal Embolizations)
---
RESOURCES
Dr. Wissam Jaber
https://providers.emoryhealthcare.org/provider/wissam-a-jaber/777074
Dr. Hady Lichaa
https://healthcare.ascension.org/find-care/provider/1336267533/hady-lichaa

Ep. 8 Low Contrast PCI: Techniques to Reduce CIN Risk with Dr. Evan Shlofmitz

Tue, 07 Oct 2025 07:00:00 -0000

Ballin’ on a contrast budget! In this episode of BackTable Cardiology, Dr. Evan Shlofmitz outlines how utilizing imaging and physiology get you the most bang for your buck when performing low contrast PCI for patients with renal impairment.
---
SYNPOSIS
Dr. Shlofmitz, co-director of Optimize PCI (OPCI) and a leading expert in intravascular imaging and physiology from St. Francis Hospital, New York, joins Dr. Sameh Sayfo, interventional cardiologist from Baylor Scott & White The Heart Hospital. Together, they delve into the importance of low contrast PCI, strategies to prevent contrast-induced nephropathy, and the use of advanced imaging techniques to aid in low contrast procedures that are critical for patients with renal impairment.
Dr. Shlofmitz shares insights into staging interventions, optimal use of contrast, and the integration of technologies like dynamic coronary roadmap and angiography-derived physiology. They also discuss the vital role of multidisciplinary collaboration, physician education, and industry support in enhancing patient outcomes by advocating for technology advancements in the cath lab. Dr. Shlofmitz highlights the Optimize PCI (OPCI) conference, which continues to advance the interventional cardiology field by providing hands-on workshops and regional courses in percutaneous cardiac procedures, imaging, access techniques, and much more.
---
TIMESTAMPS
00:00 - Introduction to Guests
02:11 - Impaired Renal Function and Contrast Induced Nephropathy
06:55 - Contrast, GFR, and Hydration Status: Cath Lab Strategies for CKD
12:24 - NCDR and Quality Metrics for CIN
15:28 - Multidisciplinary Care: Bringing Nephrology on Board
18:26 - Staging Diagnostic and Intervention Procedures to Reduce Contrast
20:39 - Ultra Low Contrast Diagnostic Angiogram Technique
25:28 - Moderate Lesions in Ultra Low Contrast
29:36 - Technology: iFR Co-registration and Diagnostic Coronary Roadmap
40:15 - Physician Champions: Advocates for Implementing New Imaging
46:33 - Optimizing PCI (OPCI) Conference
50:40 - Conclusion
---
RESOURCES
Evan Shlofmitz Provider Profile
https://doctors.catholichealthli.org/provider/evan-scott-shlofmitz/2405486
Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Lesions: 1-Year Results From the Disrupt CAD III Study
https://www.jscai.org/article/S2772-9303(21)00001-6/fulltext
Sameh Sayfo Provider Profile
https://www.bswhealth.com/physician/sameh-sayfo
Statewide Initiative to Increase Intracoronary Imaging Optimization in PCI: A Report From the BMC2 Registry
https://www.jscai.org/article/S2772-9303(25)01152-4/fulltext
Optimize PCI (OPCI) - November Hands-On Workship
https://opci.live/event/opci-michigan-2025/
Optimize PCI (OPCI)
https://opci.live/

Ep. 7 Bifurcation Interventions: Techniques and Strategies with Dr. Mirvat Alasnag

Tue, 30 Sep 2025 07:00:00 -0000

Reporting from inside the cath lab: advanced PCI techniques, cutting-edge imaging, and the future of interventional cardiology! In this episode of the BackTable Cardiology Podcast, Dr. Sameh Sayfo hosts Dr. Mirvat Alasnag, the director of research at the Cardiac Catheterization Lab at King Fahd Armed Forces Hospital in Saudi Arabia to discuss various coronary bifurcation intervention strategies, including TAP, DK Crush, and their indications.
---
SYNPOSIS
The conversation delves into the use of drug-coated balloons (DCB), intracoronary imaging techniques like IVUS and OCT, and the importance of personalized patient care in high-risk percutaneous coronary interventions (PCIs). Additionally, Dr. Alasnag addresses the challenges and innovations in supporting women in interventional cardiology and the value of mentorship and career shadowing programs for aspiring cardiologists.
---
TIMESTAMPS
00:00 - Introduction
02:06 - Understanding Bifurcation Coronary Intervention
04:00 - Strategies for Bifurcation Stenting
09:55 - The Role of Drug-Coated Balloons
13:08 - Importance of Intra-Coronary Imaging
16:31 - Global Perspectives on Bifurcation Interventions
27:57 - Advocacy for Women in Interventional Cardiology
31:42 - Mentorship and Career Guidance
---
RESOURCES
Dr. Mirvat Alasnag:
https://www.radcliffecardiology.com/authors/mirvat-alasnag?language_content_entity=en
https://esc365.escardio.org/person/367232
Dr. Sameh Sayfo:
https://www.bswhealth.com/physician/sameh-sayfo
King Fahad Armed Forces Hospital:
https://www.linkedin.com/company/king-fahad-armed-forces-hospital/?trk=public_profile_topcard_past_company&originalSubdomain=ie
New Innovations at King Fahad Armed Forces Hospital (Jeddah)
https://elixirmedical.com/king-fahad-armed-forces-hospital-begins-trial-of-new-bioadaptive-angioplasty-procedure-for-heart-disease-treatment/
Fundamentals of percutaneous coronary bifurcation interventions:
https://pmc.ncbi.nlm.nih.gov/articles/PMC8968454/
Bifurcation stenting: current strategies and new devices
https://heart.bmj.com/content/95/6/495.short

Ep. 6 Percutaneous Ventricular Assist Devices (pVADs) with Dr. Babar Basir

Tue, 23 Sep 2025 07:00:00 -0000

It’s no shock that percutaneous ventricular assist devices (pVADs) play an important role in improving cardiogenic shock outcomes (pun intended). In this episode of the BackTable Cardiology Podcast, host Dr. Sameh Sayfo interviews Dr. Babar Basir, a renowned interventional cardiologist from Michigan, about advancements and protocols in managing cardiogenic shock.

---

SYNPOSIS

Dr. Babar Basir details the history and development of the cardiogenic shock program initiated at Henry Ford Hospital, its national expansion, and its impact on patient outcomes. The conversation touches on the role of advanced heart failure specialists, ongoing trials like the Door to Unload trial, and the importance of small bore mechanical circulatory support devices. Dr. Babar Basir also highlights the significance of team-based approaches and the necessity of multidisciplinary care in improving survival rates for patients suffering from cardiogenic shock.

---

TIMESTAMPS

00:00 - Introduction
03:50 - Impella in Shock: From Last-Resort to Early Use
07:30 - National Cardiogenic Shock Initiative
14:30 - Heart Failure Readmissions
17:46 - Additional Indications for Use of Impella Device
24:10 - Future Devices and Technological Advancements in the Field
27:03 - International Advancements in Shock Initiative Protocols
30:28 - Using Impella CP vs Impella 5.5
38:20 - SCAI Shock Conference and Importance of Attending

---

RESOURCES

Dr. Sameh Sayfo:
https://www.bswhealth.com/physician/sameh-sayfo

Dr. Babar Basir:
https://www.henryford.com/physician-directory/b/basir-mir

National Cardiogenic Shock Initiative
https://www.henryford.com/cardiogenicshock

Unloading the Left Ventricle Before Reperfusion in Patients With Anterior ST-Segment-Elevation Myocardial Infarction (also known as “Door to Unload Trial”):
https://pubmed.ncbi.nlm.nih.gov/30586728/

Upcoming SCAI Shock Conference September 18th-20th, 2025
https://scai.org/education-and-events/events-schedule/2025-scai-shock-0

Ep. 5 Calcium Modification in Coronary Artery Disease: IVL or Atherectomy? with Dr. Yader Sandoval

Tue, 16 Sep 2025 07:04:00 -0000

Calcium belongs in the bones, not the blood vessels! But once it’s there, how can interventional cardiologists use their skills and tools to combat it? In this episode of the BackTable Cardiology Podcast, host Dr. Hady Lichaa interviews Dr. Yader Sandoval from the Minneapolis Heart Institute about handling coronary calcification.

---

SYNPOSIS

Dr. Sandoval shares insights into the challenges of treating calcified coronary lesions, the importance of intravascular imaging, and his strategic approach to using technologies like intravascular lithotripsy, atherectomy, and specialty balloons. He emphasizes practical tips and tricks for interventional cardiologists to optimize procedure outcomes and tackle severe coronary calcification effectively. Their discussion overviews the latest innovations in the field, providing valuable advice for balancing advanced techniques with procedural efficiency.

Dr. Sandoval also details the where, when, and how of approaching in-stent restenosis (ISR), including how to use imaging to optimize treating heavy calcifications around stents.

---

TIMESTAMPS

00:00 - Introduction
01:57 - Overview of Coronary Calcification
08:08 - Severe Calcification Cases: Equipment and Technique
21:08 - Guide Wires, Microcatheters, and Guide Extensions for Calcified Lesions
31:24 - IVUS vs OCT
36:21 - Atherectomy vs IVL Considerations
43:32 - Calcified Nodules
51:06 - Stents and In-Stent Restenosis Management
56:42 - Conclusion

---

RESOURCES

Dr. Yader Sandoval
https://mplsheart.org/yader-sandoval-md
Abbott Northwestern Hospital

Dr. Hady Lichaa
https://healthcare.ascension.org/find-care/provider/1336267533/hady-lichaa

SCAI Expert Consensus Statement on Management of In-Stent Restenosis and Stent Thrombosis
https://pmc.ncbi.nlm.nih.gov/articles/PMC11308135/

Ep. 4 Techniques for Effective Vessel Prep with Dr. Jay Mathews and Dr. Michael Siah

Tue, 16 Sep 2025 07:03:00 -0000

The toolbox for vessel preparation is rapidly expanding. Are you keeping up? In this episode, host Dr. Sabeen Dhand is joined by Dr. Jay Mathews, interventional cardiologist (Manatee Memorial Hospital) and Dr. Michael Siah, vascular surgeon (UT Southwestern), to explore the latest innovations and strategies in vessel prep.

---

This podcast is supported by:

Cagent Vascular
https://cagentvascular.com/

---

SYNPOSIS

The discussion opens with a look at new additions to their practice over the past few years, including bioresorbable scaffolds for below-the-knee interventions and retrievable stent technologies. Both experts emphasize the role of imaging—particularly CT angiography and IVUS—and discuss how renal disease impacts their use of contrast during diagnosis and intervention. They then walk through how they assess vessels on angiography or IVUS to decide when and where to use specialty tools. From intravascular lithotripsy for managing dense calcification to serration angioplasty, the conversation highlights how the doctors decide to use specialty balloons and devices. The episode also touches on the practical challenges of balancing device cost with treatment effectiveness. The physicians break down the latest specialty balloons and devices and touch on their own experiences with them. To close, the guests share what emerging technologies they’re most excited about and how these devices could change their day-to-day practice. Whether you’re in IR, cardiology, or vascular surgery, this episode offers a valuable roadmap to the current and future state of vessel preparation.

---

TIMESTAMPS

00:00 - Introduction
04:07 - New Changes in Techniques
14:57 - Vessel Characteristics on Angiogram
18:10 - Approaches to Above-the-Knee vs. Below-the-Knee Disease
23:48 - Latest Specialty Balloons
46:14 - New Devices on the Horizon
50:58 - Words of Advice and Final Thoughts

---

RESOURCES

POINT FORCE Registry:
https://evtoday.com/news/cagent-initiates-point-force-registry-of-serranator-pta-catheter?c4src=news

Ep. 3 Navigating Coronary Tortuosity in Complex Interventions with Dr. Alex Truesdell

Tue, 16 Sep 2025 07:02:00 -0000

How do you navigate tortuous coronary vasculature? In this episode of BackTable Cardiology, Dr. Hady Lichaa hosts Dr. Alexander Truesdell, an interventional cardiologist with extensive experience in overcoming complex cases of vessel tortuosity.

---

SYNPOSIS

Beginning with Dr. Truesdell’s background and expertise, the discussion delves into best practices for evaluating and navigating tortuous anatomy both diagnostically and interventionally, the use of various wires, guides, and support techniques, and how to effectively use imaging and atherectomy tools. They also touch on practical aspects of tackling coronary tortuosity, like procedural preparation, equipment choices, and the importance of continuous learning in an evolving area of medicine.

---

TIMESTAMPS

00:00 - Introduction
02:07 - Approaching Cases of Extreme Tortuosity
14:04 - Defining Tortuosity of the Coronary Vessels
18:40 - Guide Size and Equipment Strategy in Complex PCI
35:04 - Distal Guide Extension Catheter Use and One Potential Risk
43:16 - Using Imaging Catheters
49:25 - Discussion of Avoiding Complications
57:40 - Selecting Stents
01:04:00 - Guide Extension Use Through Pseudo Lesions to Decrease Ischemic Time
01:11:00 - Parting Advice for New and Mid-Career Interventional Cardiologists

---

RESOURCES

Dr. Alexander Truesdell’s Provider Profile:
https://www.virginiaheart.com/find-a-provider/physicians/alexander-g-truesdell

Dr. Hady Lichaa’s Provider Profile:
https://healthcare.ascension.org/find-care/provider/1336267533/hady-lichaa

Transradial Peripheral Vascular Intervention: Challenges and Opportunities:
https://www.openaccessjournals.com/articles/transradial-peripheral-vascular-intervention-challenges-and-opportunities.html

Ep. 2 Cardiogenic Shock Management: Latest Strategies and Innovations with Dr. Amir Kaki

Tue, 16 Sep 2025 07:01:00 -0000

In 2024, the DanGer Shock trial changed cardiogenic shock guidelines and affected practice patterns internationally. This episode of the BackTable Cardiology Podcast explores tips, tricks, and best practices in utilizing Impella, ECMO, and national initiatives to most effectively treat patients with cardiogenic shock. Host Dr. Sameh Sayfo interviews Dr. Amir Kaki, a noted interventional cardiologist and Director of Mechanical Circulatory Support and Complex PCI at Henry Ford St. John Hospital in Detroit.

---

SYNPOSIS

The discussion centers on the advances in mechanical circulatory support devices like Impella and ECMO, their history, usage criteria, and impact on patient outcomes. Dr. Kaki details the landmark Detroit Cardiogenic Shock Initiative, the challenges surrounding ECMO use, and the critical implementation of the recent DanGer-SHOCK Trial in clinical practice. After outlining the history of interventions for cardiogenic shock and the significance of recent trials within the field, he emphasizes the necessity for contemporary cardiologists to be skilled in endovascular techniques.

---

TIMESTAMPS

00:00 - Introduction
02:12 - National Cardiogenic Shock Initiative
06:23 - Shock 2 Trial
07:48 - ECLS-SHOCK Trial and ECMO
15:05 - DanGer Trial
22:56 - Parameters for Impella RP vs Impella CP Use in Cardiogenic Shock
29:39 - Impella Considerations: Placement, Limb Ischemia, Removal
37:56 - Modern Cardiogenic Shock: Overview and Resources
40:16 - Conclusion

---

RESOURCES

The National Cardiogenic Shock Initiative:
https://www.ahajournals.org/doi/10.1161/JAHA.123.031401

DanGer Shock Trial:
https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2024/04/05/04/44/danger-shock

Large-Bore Access Site Management
https://assets.bmctoday.net/citoday/pdfs/cit0719_SF2_Kaki.pdf

Short-Term Mechanical Circulatory Support for Cardiogenic Shock
https://scai.org/publications/ebooks/short-term-mechanical-circulatory-support-cardiogenic-shock

Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
https://www.nejm.org/doi/full/10.1056/NEJMoa1208410

Extracorporeal Life Support in Infarct-Related Cardiogenic Shock
https://www.nejm.org/doi/full/10.1056/NEJMoa2307227

Dr. Amir Kaki, MD
https://www.heartteam.com/provider/amir-kaki-md
https://scai.org/about-us/scai-staff-listing/amir-kaki-md-fscai

Dr. Sameh Sayfo
https://www.bswhealth.com/physician/sameh-sayfo

Ep. 1 Large Bore Access: Tools, Techniques, and Tips with Dr. Jason Wollmuth

Tue, 16 Sep 2025 07:00:00 -0000

What are the biggest challenges in large bore access and closure? In our inaugural episode of the BackTable Cardiology Podcast, Dr. Hady Lichaa hosts Dr. Jason Wollmuth, an interventional cardiologist renowned for his expertise in large bore access techniques.

---

SYNPOSIS

Dr. Wollmuth shares his journey in interventional cardiology, detailing his early experiences managing complex PCI cases and CTOs. They delve into the specifics of large bore access, including preparation and imaging, access techniques, managing complications, and the use of single access for complex cases. The discussion also covers equipment preferences, handling vascular disease, mitigating limb ischemia, and alternative access strategies such as axillary and carotid approaches. Dr. Wollmuth highlights the importance of procedural practice, interdisciplinary collaboration, and continued learning from experienced colleagues.

---

TIMESTAMPS

00:00 - Introduction
01:46 - Large-bore Access Adoption
08:00 - Micropuncture Technique for Initial Access
11:30 - Challenges of Getting Antegrade Access
17:20 - Practicing Emergent Scenarios in Non Emergent Settings
22:09 - Managing Calcified or Tortuous Arteries
44:00 - Limb Ischemia Mitigation
54:46 - The Sideclose Technique
01:01:00 - Single Access Closure Method
01:09:00 - Using Axillary Access Instead of Femoral

---

RESOURCES

Dr. Jason Wollmuth’s Provider Profile:
https://www.providence.org/doctors/interventional-cardiology/or/portland/jason-wollmuth-1164498499

Dr. Hady Lichaa’s Provider Profile:
https://healthcare.ascension.org/find-care/provider/1336267533/hady-lichaa

The Sideclose Technique: A Novel Method for Achieving Hemostasis With an Indwelling Impella CP:
https://www.jscai.org/article/S2772-9303(24)01363-2/pdf

Introducing Backtable Cardiology

Tue, 02 Sep 2025 18:00:00 -0000